Investors contact details
Investors and analysts
Investor Relations UK
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5000
Email: GSK.Investor-Relations@gsk.com
Individual shareholders
Registrar
Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex BN99 6DA
Shareholder enquiries and annual report order-line
0371 384 2991 (inside the UK)
+44 121 415 7067 (outside the UK)
Shareview Dealing Service
0345 603 7037
Equiniti Share Dealing (Investment Account / ISA)
Tel: 0345 300 0430 (UK)
Tel: +44 121 415 0105 (Overseas)
Lines are open 8.00am to 4.30pm for dealing, and until 6.00pm for enquiries Monday to Friday (excluding UK public holidays)
Employee shareholders
GSK employee shareholder enquiries
Glaxo Wellcome and SmithKline Beecham
corporate PEPs
The Share Centre Limited
Oxford House
Oxford Road
Aylesbury
Bucks HP21 8SZ
Corporate share dealing facility
Equatex UK
1 King William Street
London EC4N 7AR
Tel: 0808 234 9321 (UK)
Tel: +800 4020 0032 (International)
www.equateplus.com
Computershare UK
Computershare Plan Managers
Bridgwater Road
Bristol
BS99 6AP
Europe: (+44) 117 240 2520
North or South America: (+1) 732 491 0715
North America (Toll Free): (+1) 866 627 2097
Australia or Asia-Pacific region: (+61) 3 9415 4824
GSKLTI@computershare.com
Find out more about us
-
Investors
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
-
Shareholder information
Information and tools for shareholders including dividend calculator, share management tools, and advice on how to avoid share scams
-
Quarterly results
Discover our latest financial performance announcement and search for historical quarterly results materials
-
Governance
At GSK we are committed to operating at the highest standards of corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders.
Investors and analysts
US Investor Relations and Response Centre
GlaxoSmithKline plc
5 Crescent Drive
Philadelphia PA 19112
Toll free: +1 888 825 5249
Tel: +1 215 751 4000
Email: GSK.Investor-Relations@gsk.com
Individual shareholders
J.P. Morgan Chase Bank
Registrar: EQ Shareowner Services
PO Box 64504
St. Paul
MN 55164-0504
Overnight correspondence should be sent to:
EQ Shareowner Services
1110 Centre Point Curve
Suite 101
Mendota Heights
MN 55120-4100
Website: www.shareowneronline.com
Tel: +1 877 353 1154 (US toll free)
Tel: +1 651 453 2128 (outside the USA)
Email anytime at www.shareowneronline.com by selecting Contact Us.
The Depositary also provides Global Invest Direct, an ADS purchase/sale and dividend reinvestment plan for ADR holders. Current participants in the BNY Global BuyDIRECT will receive a welcome letter via US Mail with instructions for activating their new Global Invest Direct account.
Further information regarding signing up for Global Invest Direct can be obtained by visiting www.shareowneronline.com or call the above helpline number to obtain an enrollment pack.
Employee shareholders
Corporate share dealing facility
Equatex US Inc.
140 BroadwaySuite
2211 New York,
NY 10005
Tel: +41 44 403 61 00
www.equateplus.com
Computershare US
Computershare Plan Managers
Bridgwater Road
Bristol
BS99 6AP
Europe: (+44) 117 240 2520
North or South America: (+1) 732 491 0715
North America (Toll Free): (+1) 866 627 2097
Australia or Asia-Pacific region: (+61) 3 9415 4824
GSKLTI@computershare.com
Find out more about us
-
Investors
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
-
Shareholder information
Information and tools for shareholders including dividend calculator, share management tools, and advice on how to avoid share scams
-
Quarterly results
Discover our latest financial performance announcement and search for historical quarterly results materials
-
Governance
At GSK we are committed to operating at the highest standards of corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders.